DB
AXSM icon

Danske Bank’s Axsome Therapeutics AXSM Stock Holding History

Danske Bank’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$18.3K – 1212
2025
Q4 		$18.3K Hold
100
– – ﹤0.01% 1215
2025
Q3 		$12.1K Hold
100
– – ﹤0.01% 1240
2025
Q2 		$10.4K Buy
+100
New +$10.6K ﹤0.01% 1284
2024
Q4 		– Sell
-200
Closed -$18K – 1442
2024
Q3 		$18K Buy
+200
New +$17.5K ﹤0.01% 1347

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Danske Bank's AXSM Position: Q1 2026 in Review

Danske Bank sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 100 shares — an estimated $18.3K sold.

Danske Bank first reported a position in AXSM in Q3 2024 and held it in 4 quarters. The position peaked at $18.3K in Q4 2025. 410 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Danske Bank reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Danske Bank sold 100 Axsome Therapeutics shares in Q1 2026, an estimated $18.3K.
  • Danske Bank first reported a position in Axsome Therapeutics in Q3 2024 and held it in 4 quarters.
  • Danske Bank's Axsome Therapeutics position peaked at $18.3K in Q4 2025.
  • 410 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.